Warning letter
Peter Schiff Enterprises: warning letter of Jul 31, 2013
FDA warning letter 406601 · New Orleans District Office
Key facts
| Reference number | 406601 |
|---|---|
| Company | Peter Schiff Enterprises |
| Subject | Quality System Regulation for Medical Devices/Adulterated |
| Issue date | Jul 31, 2013 |
| Posted date | Jul 31, 2013 |
| Issuing office | New Orleans District Office |
| Product type | Devices |
| CFR sections cited | 820, 820.40 |
| Inspection city | Cookeville |
| Inspection ZIP | 38506 |
| Inspection start date | Mar 22, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: